Cell-Free Fat Extract for Osteoporosis Bone Density
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for osteoporosis are not ideal, necessitating a more effective therapeutic option to prevent and treat the condition by improving bone density, mass, and microstructure.
Innovation Solution
A cell-free fat extract is used, obtained through a specific preparation process involving centrifugation and emulsification of fatty tissue, which is rich in growth factors like IGF-1, BDNF, and VEGF, to create a composition that can be administered for preventing and treating osteoporosis, increasing bone volume fraction, and enhancing bone mineral density.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional drugs are used for osteoporosis treatment, then the treatment can be administered, but the therapeutic effect is not ideal
Solution Approach 1:
The invention extracts and utilizes specific growth factors (IGF-1, BDNF, VEGF, etc.) from adipose tissue to create a targeted therapeutic composition. This extraction principle allows the patent to isolate the beneficial components responsible for bone formation and regeneration, thereby improving therapeutic effectiveness while avoiding the limitations of conventional drugs.
Solution Approach 2:
The patent changes the fundamental parameter of treatment approach by shifting from conventional pharmacological agents to a composition enriched with specific growth factors. This parameter change enables superior therapeutic effects on bone density, bone mass, and microstructure by utilizing the natural bone-forming capabilities stimulated by these growth factors.
2Reliability
If a cell-free fat extract is prepared through centrifugation and emulsification, then the extract is free of cells and lipid droplets, but the preparation process becomes complex
Solution Approach 1:
The preparation process is segmented into distinct sequential steps: centrifugation to separate cellular components, emulsification to break down lipid structures, and filtration to remove remaining particles. This segmentation allows each step to target specific contaminants, achieving high purity through a systematic multi-stage process rather than a single complex operation.
Solution Approach 2:
The patent uses an intermediary emulsification step that facilitates the separation of lipid droplets from the aqueous phase containing growth factors. This intermediary process acts as a bridge between the crude extract and the final purified product, enabling efficient removal of lipid contaminants while preserving the therapeutic components.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The cell-free fat extract effectively increases bone volume fraction, trabecular number, and mineral density, reducing trabecular separation, thereby providing a superior therapeutic effect for osteoporosis treatment.
Implementation Method 1
A cell-free fat extract is used, obtained through a specific preparation process involving centrifugation and emulsification of fatty tissue, which is rich in growth factors like IGF-1, BDNF, and VEGF
Implementation Method 2
The cell-free fat extract effectively increases bone volume fraction, trabecular number, and mineral density, reducing trabecular separation
Data Source
AI summary
A cell-free fat extract is used for the preparation of a composition or a formulation. The composition or the formulation is effective in (i) preventing and/or treating osteoporosis; (ii) increasing bone volume fraction; (iii) increasing trabecular number; (iv) increasing trabecular connectivity density; (v) increasing bone mineral density; (vi) increasing trabecular thickness; and/or (vii) reducing trabecular separation.